HAYDEN JEREMY B. 4
4 · Sight Sciences, Inc. · Filed Nov 14, 2025
Insider Transaction Report
Form 4
HAYDEN JEREMY B.
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-12$1.96/sh+2,440$4,782→ 259,030 total - Exercise/Conversion
Common Stock
2025-11-12$1.96/sh+710$1,392→ 259,740 total - Sale
Common Stock
2025-11-12$8.01/sh−3,150$25,232→ 256,590 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-12−2,440→ 0 totalExercise: $1.96Exp: 2030-05-10→ Common Stock (2,440 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-12−710→ 0 totalExercise: $1.96Exp: 2030-07-28→ Common Stock (710 underlying)
Footnotes (4)
- [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse. The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions.
- [F2]Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan.
- [F3]Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The options are fully vested and exercisable.